XM does not provide services to residents of the United States of America.

Mettler-Toledo forecast dull third-quarter profit on weak China demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Mettler-Toledo forecast dull third-quarter profit on weak China demand</title></head><body>

Aug 1 (Reuters) - Medical equipment maker Mettler-Toledo International MTD.N forecast third-quarter profit below estimates on Thursday, a sign of a weaker-than-expected recovery in sales in its key market China.

Lifesciences firms including lab equipment maker Mettler-Toledo have seen sluggish demand for their instruments used in drug development as cash-strapped biotech clients try to navigate a funding crunch amid high interest rates.

Slowing growth in China has further crimped demand forMettler. In its first-quarter earnings, the company had flaggedthat it continued to see softness in China.

"As expected, market conditions in China remained weak," said CEO Patrick Kaltenbach.

The firm expects third-quarter adjusted profit to be in the range of $9.90 to $10.05 per share, below estimates of $10.36 per share.

Its quarterly sales fell 4% to $946.8 million, above analysts' average estimate of $929.1 million.

The Columbus, Ohio-based firm reported adjusted profit for the quarter of $9.65 per share, versus analysts' expectations of $9.03 per share.

Even though the company raised its 2024 adjusted profit to be in the range of $40.20 to $40.50 per share, from its previous range of $39.90 to $40.40 apiece, its midpoint came 5 cents below estimates.

Analysts, on average, expect a profit of $40.40 per share, for the year, according to LSEG data.

Peer Waters Corp WAT.N lowered its annual profit forecast last week, as it anticipates reduced demand for its products and services used in drug development and research.



Reporting by Vaibhav Sadhamta; editing by Alan Barona

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.